2021, Number 4
<< Back Next >>
Rev Nefrol Dial Traspl 2021; 41 (4)
Capacity of continuous dialysis therapies in Peru for COVID-19 patients with acute kidney injury
Herrera- Añazco P, León-Rabanal C, Valdivia-Vega RP
Language: Spanish
References: 6
Page: 311-312
PDF size: 142.49 Kb.
Text Extraction
No abstract.
REFERENCES
Claure-Del Granado R, Casas-Aparicio G, Rosa-DiezG, Rizo-Topete L, Ponce D. Renal replacement therapyfor acute kidney injury in COVID-19 patients in LatinAmerica. Kidney Blood Press Res. 2020;45(6):775-83.doi: 10.1159/000511914.
Benites-Flores IR, Valdivia-Vega RP, Alcalde-RuizSF, Espinoza-Rojas HJ. Clinical characteristics ofacute kidney injury in the first 13 critically ill patientsinfected with SARS-CoV-2 at a Peruvian hospital: apreliminary report. J Nephropathol. 2021;10(2):e15.doi: 10.34172/jnp.2021.15.
Nash DM, Przech S, Wald R, O’Reilly D. Systematicreview and meta-analysis of renal replacement therapymodalities for acute kidney injury in the intensivecare unit. J Crit Care. 2017;41:138-44. doi: 10.1016/j.jcrc.2017.05.002.
Reddy YNV, Walensky RP, Mendu ML, Green N,Reddy KP. Estimating Shortages in Capacity to DeliverContinuous Kidney Replacement Therapy Duringthe COVID-19 Pandemic in the United States. AmJ Kidney Dis. 2020;76(5):696-709.e1. doi: 10.1053/j.ajkd.2020.07.005.
Perú. Ministerio de Salud. Sala situacional COVID-19Perú [Internet]. Disponible en: (consulta: 23/11/2020).
Herrera-Añazco P, Atamari-Anahui N, Flores-BenitesV. Número de nefrólogos, servicios de hemodiálisisy tendencia de la prevalencia de enfermedad renalcrónica en el Ministerio de Salud de Perú. Rev PerúMed Exp Salud Pública. 2019;36(1):62-7. doi: 10.17843/rpmesp.2019.361.4253.
Full text